Recent Articles from Investor Brand Network

Backers of a proposed medical marijuana measure in Idaho say they have surpassed 100,000 collected signatures and are now racing to meet an April 30 deadline that would place the issue before voters in November.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Massimo Group (NASDAQ: MAMO) announced the appointment of Quenton Petersen as Chief Executive Officer, effective April 14, 2026, with David Shan transitioning to Executive Chairman while remaining actively involved in the Company’s strategic direction. Petersen, a nine-year veteran of the company, emphasized continued growth across utility vehicles and electric mobility, alongside a disciplined evaluation of opportunities to integrate advanced technologies such as AI-enabled features and expand into applications including facility operations and smart mobility.

Genius Group (NYSE: GNS) announced the closing of its previously disclosed registered direct offering, raising gross proceeds of approximately $8.0 million through the sale of 21,621,621 ordinary shares (or pre-funded warrants in lieu thereof). The offering was conducted under the Company’s effective shelf registration statement, with D. Boral Capital LLC serving as exclusive placement agent, and proceeds are expected to support the Company’s continued growth as an AI-powered education platform.

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader

Sustained investment in wind and hydroelectric infrastructure has pushed electricity prices in parts of Scandinavia to historic lows. Prices have fallen below zero in some places due to abundant renewable energy supply, an outcome that has established the Nordic region as a working model of what a mature clean energy transition can deliver.

Alabama is preparing to roll out its long-awaited medical cannabis program, with the first dispensary set to open in the state capital next month.

Channelchek, a Noble Financial Group platform, highlights a changing investment landscape in 2025, where capital is increasingly rotating toward differentiated growth opportunities beyond crowded sectors. Within this environment, Enhanced Group Inc.—an emerging sports, media, and consumer health company— is pursuing a public market debut through a proposed business combination with A Paradise Acquisition Corp. (NASDAQ: APAD) , positioning itself within a more selective and disciplined SPAC market.

Wearable Devices (NASDAQ: WLDS) announced a planned cooperation and partnership with Meta-Bounds Inc. to integrate its Mudra neural wristband technology with augmented reality hardware, aiming to enable seamless, touchless spatial interaction. The companies intend to showcase early results of the collaboration at Augmented World Expo 2026 in Long Beach, California, with an initial focus on developing wristband-based controls for AR glasses and a longer-term strategy centered on enterprise partnerships and scalable B2B integration.

Oragenics (NYSE American: OGEN) announced that two patients have been enrolled and eight doses administered in its ongoing Phase IIa clinical trial evaluating ONP-002, its lead candidate for the treatment of mild traumatic brain injury (mTBI), or concussion. The trial is underway at Mackay Base Hospital in Queensland, Australia, with additional sites nearing activation, as the company advances a first-in-class intranasal neurosteroid designed to target the underlying biological effects of brain injury, addressing a significant unmet need in a market with no FDA-approved pharmacological treatments.

OptimumBank Holdings (NYSE American: OPHC) announced that Brean Capital, LLC has initiated equity research coverage of the company, with Director of Research Christopher Marinac assigning a Buy rating and an $8 price target. The report, distributed to Brean’s institutional client base, underscores growing recognition of the company’s business model, operating performance and long-term growth strategy, according to Chairman Moishe Gubin, who highlighted the initiation as a key step in expanding investor awareness.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, is advancing its strategy to embed mortgage and title services directly into digital real estate platforms, with a newly announced partnership with Structured Real Estate Group (“SRG”). The agreement, detailed in a company press release, positions Beeline’s technology inside SRG’s AI-driven property ecosystem, allowing users to move from property selection to financing without leaving a single interface ( https://ibn.fm/DEI7p ).

Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage highlighting a fundamental shift in biotechnology, where scientific progress is increasingly recognized as measurable financial value rather than purely as research expenditure. As clinical-stage assets advance toward commercialization, fair-value accounting frameworks under U.S. GAAP are enabling companies to reflect pipeline progress, probability of success and timing of market entry directly on the balance sheet. Within this evolving landscape, Oncotelic exemplifies the trend through its diversified oncology pipeline and strategic holdings, including its 45% stake in GMP Bio, recently measured at an enterprise value exceeding $1 billion, demonstrating how advancing science can materially strengthen financial positioning.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Aditxt (NASDAQ: ADTX) announced its precision oncology subsidiary, Ignite Proteomics, was featured in a peer-reviewed study published in npj Precision Oncology, a Nature journal, evaluating treatment outcomes in metastatic breast cancer patients receiving trastuzumab deruxtecan. The study found that quantitative HER2-related assays, including Ignite’s Reverse Phase Protein Array platform, provided more predictive insight into patient outcomes than traditional immunohistochemistry methods in certain sub-cohorts, highlighting the potential of advanced biomarker approaches to improve treatment selection in oncology.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Lantern Pharma (NASDAQ: LTRN) announced it has scheduled a mid-May 2026 Type C meeting with the U.S. Food and Drug Administration to seek feedback on proposed protocol amendments to its Phase 2 HARMONIC(TM) trial evaluating LP-300 in non-small cell lung cancer. The proposed changes include focusing enrollment on EGFR Exon 21 L858R patients, shifting to a single-arm study design and extending treatment cycles, supported by emerging clinical data showing an 8.3-month median progression-free survival and encouraging response rates in this difficult-to-treat population.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

NRx Pharmaceuticals (NASDAQ: NRXP) welcomed a newly signed Executive Order aimed at accelerating medical treatments for serious mental illness, including expanded access to psychedelic therapies and faster regulatory pathways. The order directs the FDA to issue priority vouchers for qualifying breakthrough therapies and encourages broader use of clinical trial data and real-world evidence, aligning with NRx’s strategy as it advances its NRX-100 drug candidate and seeks regulatory support to address severe depression, PTSD and suicidality.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Most digital communications are secured by encryption built on mathematical problems so hard that conventional computers cannot realistically solve them. That assumption could soon be broken by quantum computers that exploit properties of matter at subatomic scales to perform certain calculations far more efficiently than conventional machines ever could.

Snapchat’s parent company, Snap Inc., has announced a major round of layoffs, cutting about 1,000 jobs, which is around 16 percent of its workforce. The company is also removing hundreds of open job listings as it shifts its focus toward a leaner and more efficient way of operating. This decision reflects a growing trend in the tech industry where companies are turning to artificial intelligence to handle routine tasks that were once done by humans.

Gold ended the week trading within a limited range as traders and investors remained uncertain about the near-term outlook of prices. Investors remain cautious as there is uncertainty about how talks between the United States and Iran will play out while the clock is ticking down on the 14-day ceasefire that paved the way for these talks.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

AINewsWire Editorial Coverage : For decades, GPS has operated as the invisible infrastructure underpinning modern warfare, enabling everything from precision-guided munitions to autonomous drone navigation. That assumption of reliability is now disappearing in real time. Across active conflict zones, satellite navigation signals are being jammed, spoofed and degraded at scale, turning one of the most trusted systems in defense into one of its most vulnerable. The consequences are immediate and measurable: Drones lose positioning, missions fail mid-operation and entire systems become ineffective in contested environments. As electronic warfare capabilities advance, GPS is increasingly becoming the first system adversaries attempt to disable, forcing a rapid reassessment of how modern platforms operate without it. In response, defense organizations worldwide are accelerating the search for alternatives that can function independently of satellite signals.

Blockchain Futurist Conference announced a six-year exclusive partnership with Krown Technologies, Inc., naming Krown Network the Exclusive Official Quantum Blockchain and Qastle Wallet the Exclusive Official Quantum Wallet across its Toronto and Florida events beginning in 2026. The agreement grants Krown category exclusivity across both flagship markets and includes major branded activations such as The Krown Network Main Stage, a Florida title-level presence and a Toronto VIP cabana experience, positioning Krown’s quantum-secured blockchain ecosystem and Qastle Wallet’s digital asset platform at the center of engagement with founders, investors, developers, enterprises, media and the broader Web3 community.

BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector historically defined by long timelines and uncertain outcomes. As drug candidates advance closer to commercialization, scientific progress is no longer viewed solely as research expenditure but increasingly as a measurable financial asset. This shift is being reinforced by fair-value accounting under U.S. GAAP, which allows life sciences companies to reflect clinical progress, probability of success and commercialization timing as measurable balance sheet value. Leading companies, such as Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), are keenly aware of this evolution and are leveraging their expertise as pioneers in this space. Through its diversified pipeline and strategic holdings, including a 45% ownership stake in GMP Bio, which was recently measured at more than $1 billion enterprise value, the company exemplifies how advancing science can directly influence financial positioning. As the biotech sector increasingly aligns valuation with progress rather than revenue alone, Oncotelic provides a case study in how innovation is becoming a recognized asset class. Oncotelic joins an elite group of other key companies focused on advanced biotech platforms that target disease at the genetic or molecular level, including Sarepta Therapeutics Inc. (NASDAQ: SRPT), Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and…

Safe Pro Group (NASDAQ: SPAI) reported continued execution of its share repurchase program, with 400,000 shares repurchased as of April 17, 2026, representing approximately 3.5% of its public float under a $3.0 million authorization approved in December 2025. The company funded repurchases through operating cash flow and its strong balance sheet, which included $16.7 million in cash and no debt at year-end 2025, and said it may continue opportunistic buybacks while investing in its AI-enabled defense and security platform and long-term growth initiatives.

The Nebraska Medical Cannabis Commission has approved a set of rules governing the state’s emerging cannabis supply system, almost a year after first adopting temporary guidelines.

Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the industry,” reads a recent article.

Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. By inhibiting PP2A, the compound stimulates cell-cycle progression and interferes with DNA repair in cancer cells, potentially making tumors more responsive to chemotherapy and immunotherapy. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with significant unmet medical need, including ovarian clear cell carcinoma, metastatic colon cancer and advanced soft tissue sarcoma.”

Artificial intelligence-powered cardiovascular medicine company Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its focus on cardiovascular disease prevention, detection, and management. The publication reads, “The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators… At the core of its strategy is the integration of epigenetics, genetics, and artificial intelligence to generate insights from a patient’s molecular profile. By analyzing both inherited predisposition and changes influenced by lifestyle and environment, the company’s platform is designed to provide a more complete view of cardiovascular disease.”

Suntex Enterprises (OTC: SNTX) announced the filing of its annual financial statements, highlighting a completed operational restructuring and simplified capital structure with no outstanding debt or convertible instruments. The company also confirmed submission of a corporate action to FINRA seeking approval for a shareholder dividend tied to a diversified portfolio of operating businesses, as Suntex advances a strategy focused on scaling its subsidiaries through organic growth and acquisitions while targeting approximately $100 million in annual revenue and evaluating potential uplisting opportunities.

Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient needs are urgent. Soligenix (NASDAQ: SNGX) has secured that type of validation, as the European Commission granted orphan drug designation to its investigational therapy SGX945 for the treatment of Behçet’s disease, reinforcing both the promise of the therapy and the company’s broader development strategy.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Cancer treatment is entering a phase where the question is no longer which single therapy works best, but how treatments can be combined to improve outcomes. Across oncology, resistance and relapse remain persistent challenges, and the industry’s response has been increasingly clear: multi-drug regimens targeting different biological pathways are delivering results that single agents cannot.

Despite strong support for fossil fuels under the Trump administration, renewable energy in the United States continued to expand last year, reaching new highs. Clean energy sources generated about 26% of the country’s electricity, which equates to enough power for more than 100 million homes for a year. Renewables also accounted for about 33% of total utility-scale capacity, highlighting their growing importance in the national energy mix.

A new study suggests that generative AI has yet to develop the level of reasoning required for safe use in clinical settings. While recent systems show stronger performance when given detailed patient information, researchers found they still struggle with one of the most critical aspects of medical decision-making.

N issan has unveiled plans to transform vehicular mobility using a combination of electrification, artificial intelligence (AI), and a vehicle lineup focused on the global market. Although the Japanese carmaker did not go all-in on electrification like its Western counterparts, Nissan had a pair of fully electric models by early 2026 and has pledged to launch 19 new EV models by the end of the decade .

A survey that was conducted toward the end of last year by Gallup and West Health found that a sizeable number of Americans are using AI to supplement their interactions with healthcare providers. However, the specifics of how people used these digital tools varied based on age groups, income level and motivations.

Britain’s grid operator is launching a program encouraging households to increase electricity consumption this summer during periods when renewable generation exceeds network capacity. National Energy System Operator plans to alert energy suppliers when surplus wind and solar output overwhelms absorption capability, allowing companies to offer customers free or discounted electricity during those windows.

Bitcoin climbed past the $75,000 mark earlier in the week, reaching its highest level in nearly a month and signaling a shift in market sentiment after weeks of uncertainty. The move marks the first time the crypto has traded at this level since mid-March, following renewed optimism surrounding easing geopolitical tensions in the Middle East.

Lawmakers in Maine have signed off on a bill designed to place a moratorium on the construction of data centers within the state. If signed into law, the legislation would be the first such measure in the entire United States and could set the pace for nearly a dozen other states considering similar proposals.

Southeast Asia’s e-commerce sector continued its strong rise in 2025, reaching a total value of $157 billion, according to a new report by Momentum Works. This growth shows how online shopping is becoming a major part of everyday life across the region, driven by better technology, improved delivery systems, and changing consumer habits.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

Gaxos.ai (NASDAQ: GXAI) announced the expansion of its Gaxos Labs ecosystem with the addition of AI music generation, AI chat and AI 3D model creation capabilities, driving increased user engagement across its platform. The new features enhance the company’s suite of generative AI tools spanning image, video and text applications, as Gaxos advances its strategy to deliver scalable, creativity-focused solutions for consumer, creator and commercial markets while capitalizing on growing global demand for AI-driven content generation.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common stock, generating gross proceeds of $10 million before expenses, with the transaction completed on April 16, 2026. The offering, supported by key stakeholders including ClearCardio(TM), company leadership and institutional investors, will fund commercialization of HeartBeam’s FDA-cleared 12-lead synthesized ECG system, further development of its extended-wear patch and heart attack detection technologies, expansion of AI capabilities and general corporate purposes

This article has been disseminated on behalf of Search Minerals Inc. and may include paid advertising.

Legal cannabis sales in Michigan rebounded sharply in March, even as retail prices continued to edge higher for a third month in a row, according to newly released figures from the state’s Cannabis Regulatory Agency.

Roth Capital Partners announced the appointment of Seth Appel as head of ATM and equity alternatives banking, bringing more than 30 years of capital markets experience to expand the firm’s equity capital markets capabilities and support growth companies in raising capital. In connection with the appointment, Appel will also serve as co-chief investment officer of the RoHo Capital Opportunities Fund, a joint venture with Horizon Technology Finance Corporation (NASDAQ: HRZN), focused on providing debt financing solutions to small- and micro-cap public companies.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Advancing clinical research while generating positive data is a critical combination in biotechnology, particularly when addressing diseases with limited treatment options. Soligenix (NASDAQ: SNGX) is demonstrating that momentum as it provides both an encouraging clinical update from its phase 3 FLASH2 study and positive comparative clinical results for its HyBryte therapy, reinforcing the company’s focus on developing innovative treatments for serious conditions.

Datavault AI (NASDAQ: DVLT) a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced that the first sites of its quantum-ready high-performance computing GPU network are now live in New York and Philadelphia, with full commercial availability of its planned 48,000-GPU fleet expected in Q3 2026. The network, designed to operate outside the hyperscaler supply chain, will scale across 1,000 micro-edge sites in more than 100 U.S. cities and support low-latency AI inference, data tokenization and monetization through the company’s IDE(R), DataValue(R) and DataScore(R) platforms, positioning it as an alternative source of secure enterprise AI compute capacity amid ongoing GPU supply constraints.

Latest reports show that ongoing conflict in the Middle East, particularly Iran, is beginning to strain the supply of critical processing chemicals used by cobalt and copper miners in the Democratic Republic of Congo . Several shipments of essential leaching chemicals have either been withdrawn or cancelled by suppliers, forcing mining firms to ration usage and weigh potential production cuts as disruptions tied to key shipping routes intensify.

Accelerating electric vehicle adoption and growing energy storage needs are exposing vulnerabilities in battery supply chains and increasing interest in alternatives to lithium-ion technology. While geological reserves of lithium, nickel, and cobalt exist, expanding mining and processing operations fast enough to meet surging demand presents a major long-term challenge.

Rising geopolitical strain returned to the spotlight after negotiations between Iran and the United States collapsed during talks held in Pakistan. The fallout has pushed investors toward safer assets, adding pressure to conventional markets while sending oil prices higher. In contrast, major cryptos have shown stability, even as questionable activity in lesser-known tokens casts a shadow over the broader sector.

Lung cancer is the leading cause of cancer-linked fatalities among men and women, and survival beyond five years post-diagnosis is minimal. This is largely because most cases are detected when they are already advanced. Scientists are therefore searching for ways to boost early detection so that treatment outcomes can improve and survival can increase.

A recent report published by MIT Tech Review Insights says that organizations should rethink how data consent is handled and they need to switch from the current approach in which this is regarded as a one-off consent request to an ongoing process in which consent is requested as the relationship between the organization and its clients deepens in terms of the trust audiences or customers have in that organization.

Tensions have risen between Tel Aviv and Seoul after a video shared by South Korea’s president sparked outrage and strong reactions from Israel. What began as a social media post meant to highlight human suffering quickly turned into a diplomatic disagreement between two countries that have maintained friendly relations for decades.

A newly released survey suggests AI is quickly becoming part of everyday life for many Americans, both at home and on the job. The study, published by Epoch AI, found that about 50% of adults in the U.S. reported using AI tools at least once in the last week. Among those employed full-time, 20% said certain aspects of their work are now handled by AI systems.

Oncotelic Therapeutics (OTCQB: OTLC) is signaling a significant strategic evolution, moving beyond its roots as a clinical-stage biotechnology company into the quickly expanding intersection of artificial intelligence and industrial automation. Through two closely aligned announcements, the firm has unveiled a strategic partnership with TechForce Robotics, which positions it to commercialize a next-generation, AI-enhanced platform created for regulated pharmaceutical environments ( ibn.fm/aA1Bt ).

Oncotelic Therapeutics (OTCQB: OTLC), a clinical-stage biopharmaceutical company focused on orphan oncology and advanced drug platforms, reported financial results for the fiscal year ended Dec. 31, 2025, with net income of approximately $249.0 million compared to a net loss of $4.8 million in FY 2024, primarily driven by a non-cash gain of approximately $365.4 million from the increased valuation of its GMP Biotechnology joint venture, partially offset by a deferred tax provision of $111.6 million.

Nightfood Holdings (OTCQB: NGTF), operating through its TechForce Robotics subsidiary, announced the execution of a strategic supply agreement with NUWA Robotics Corp. and Foxconn, marking its transition from development and pilot programs to commercial deployment of robotic platforms. The agreement establishes a framework for engineering, manufacturing and commercialization, with TechForce retaining exclusive intellectual property ownership while leveraging NUWA’s system integration expertise and Foxconn’s global manufacturing capabilities to scale production and support growing demand for its Robotics-as-a-Service model.

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, announced that its PharmcoRx subsidiary has deployed artificial intelligence-powered prescription intake and processing technology into its pharmacy management system. The AI-driven tools automate manual workflows including data entry, faxing and refill management to create HIPAA-compliant digital processes, and are expected to improve efficiency, reduce costs and support scalable growth as PharmcoRx expands its services and client base.

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is seeking to establish its place within the increasingly competitive fusion energy sector by sharpening its commercialization strategy, building institutional relationships, and refining its long-term market positioning.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

BluSky AI (OTC: BSAI) is positioning at the forefront of a major shift in artificial intelligence infrastructure, where flexibility and predictable access to compute resources are becoming mission critical. “With AI workloads increasing at unprecedented rates, organizations are changing their outlook on traditional hyperscale cloud providers and finding alternatives that reduce vendor lock-in, provide the compute that is quickly becoming unavailable, while enhancing cost visibility and performance reliability. The company’s approach, anchored in the design of modular and quickly deployable data centers, offers a compelling solution for this evolving landscape,” a recent article reads.

Earth Science Tech (OTC: ETST), a strategic holding company, was featured in a recent article that discussed its strives to build value by acquiring and actively managing businesses. The publication reads, “Earth Science Tech takes an approach that prioritizes capital discipline, execution, and long-term value creation across the platforms it operates, while focusing on scaling businesses that can grow sustainably and increase shareholder value. The wholly owned and majority-owned subsidies that the company operates include: Mister Meds LLC: A compounding pharmacy that delivers personalized wellness plans and dedicated support to patients across the USA… RxCompoundStore.com LLC: Another compounding pharmacy that’s authorized to fulfill prescriptions across over 20 states and Puerto Rico… Peaks Curative LLC: A company and telemedicine referral platform that provides doctor-verified telehealth treatments… Las Villas Health Care Inc.: A healthcare provider that serves the Spanish-speaking community and offers personalized wellness programs… DOConsultations LLC: A telehealth platform that offers personalized health wellness programs and supports direct delivery through the company’s partner pharmacies… Earth Science Foundation Inc.: A nonprofit organization that acts as the charitable arm of the company and provides qualified individuals with financial assistance related to prescription costs.”

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.